Eponyms in Oncology: Peutz-Jeghers Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Peutz-Jeghers syndrome.
Breast Cancer
BREAST CANCER ADVISOR
FEATURED CONTENT
-
-
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis. -
Eponyms in Oncology: Li-Fraumeni Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome. -
Racial Differences in Genomic Profiles May Help Explain Breast Cancer Outcomes
Black patients with metastatic breast cancer were less likely than their White counterparts to have actionable genetic variations. -
Advances Needed to Reduce Overdiagnosis of Breast Cancer
An estimated 15% of screen-detected breast cancer cases were overdiagnosed.
VIDEO SERIES
The Phase 3 PlanB Trial
Continue to Work?
2016 SABCS: Clinical Insights Telli
2016 SABCS: Clinical Insights Oregan
HER2-positive Metastatic and TNBC
Frontline Treatments
Treatment-related Neuropathy
ER-positive, HER2-negative
Emerging Medicines
Triple-negative Breast Cancer
Insights from the Lab and Clinic
Trastuzumab Resistance
Biologic Role of HER2
Strategies in Management
BREAST CANCER NEWS
Men With Breast Cancer Present at Later Stage, Have Worse Prognosis Than Women
Denosumab Improves Long-Term Outcomes in AI-Treated Breast Cancer
Age, Follow-Up Interval Associated With Risk of Breast Cancer-Related Lymphedema After Axillary Lymph Node Dissection
Prevalence of Cancer Among Pregnant Patients on the Rise
Nab-Paclitaxel Plus Pembrolizumab in HR+ Breast Cancer
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...